Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02311283 · ClinicalTrials.gov registry record
Pilot Study: Urea Cycle Disorders Practice Patterns and Outcomes Assessment
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 87
- Enrollment target
NCT02311283: Completed study, sponsored by University of South Florida.
NCT02311283 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02311283 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if patients participating in "The Longitudinal Study of Urea Cycle Disorders" are different than participants in the Urea Cycles Disorders Consortium (UCDC) Rare Diseases Clinical Research Network (RDCRN) Contact Registry and to determine if patients are a good source of medical information.
Primary Outcome
Patient-reported survey data will be reviewed for accuracy and feasibility as a reliable data source.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-07-01 |
What the finished NCT02311283 record still lists
NCT02311283 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02311283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02311283 about?
NCT02311283 is a clinical study titled "Pilot Study: Urea Cycle Disorders Practice Patterns and Outcomes Assessment". The purpose of this study is to determine if patients participating in "The Longitudinal Study of Urea Cycle Disorders" are different than participants in the Urea Cycles Disorders Consortium (UCDC) Rare Diseases Clinical Research Network (RDCRN) Contact Registry and to determine if patients are a g...
What is the current status of trial NCT02311283?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2014-10. Estimated completion is 2016-07-01.
Who is sponsoring clinical trial NCT02311283?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia